4.7 Article

COVID-19 Patient Health Prediction Using Boosted Random Forest Algorithm

期刊

FRONTIERS IN PUBLIC HEALTH
卷 8, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fpubh.2020.00357

关键词

COVID-19; healthcare analytics; patient data; infection; boosting; random forest classification

资金

  1. National Research Foundation of Korea (NRF) - Korea government (MSIT) [NRF-2018R1C1B5045013]
  2. National Research Foundation of Korea [21A20131600002] Funding Source: Korea Institute of Science & Technology Information (KISTI), National Science & Technology Information Service (NTIS)

向作者/读者索取更多资源

Integration of artificial intelligence (AI) techniques in wireless infrastructure, real-time collection, and processing of end-user devices is now in high demand. It is now superlative to use AI to detect and predict pandemics of a colossal nature. The Coronavirus disease 2019 (COVID-19) pandemic, which originated in Wuhan China, has had disastrous effects on the global community and has overburdened advanced healthcare systems throughout the world. Globally; over 4,063,525 confirmed cases and 282,244 deaths have been recorded as of 11th May 2020, according to the European Centre for Disease Prevention and Control agency. However, the current rapid and exponential rise in the number of patients has necessitated efficient and quick prediction of the possible outcome of an infected patient for appropriate treatment using AI techniques. This paper proposes a fine-tuned Random Forest model boosted by the AdaBoost algorithm. The model uses the COVID-19 patient's geographical, travel, health, and demographic data to predict the severity of the case and the possible outcome, recovery, or death. The model has an accuracy of 94% and a F1 Score of 0.86 on the dataset used. The data analysis reveals a positive correlation between patients' gender and deaths, and also indicates that the majority of patients are aged between 20 and 70 years.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据